Bristol Myers Squibb (BMY) Total Liabilities (2009 - 2026)

Bristol Myers Squibb (BMY) has 18 years of Total Liabilities data on file, last reported at $66.4 billion in Q1 2026.

• Total Liabilities for Q1 2026 came in at $66.4 billion, down 11.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $66.4 billion (down 11.48% YoY), and the FY2025 annual result was $71.5 billion, down 6.14% from the prior year.
• Total Liabilities fell to $66.4 billion in Q1 2026 per BMY's latest filing, from $71.5 billion in the prior quarter.
• Over five years, Total Liabilities peaked at $82.5 billion in Q1 2024 and troughed at $61.5 billion in Q2 2023.
• A 5-year average of $70.8 billion and a median of $71.4 billion in 2022 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2023 and 2024: Total Liabilities dropped 12.6% in 2023, then soared 32.19% in 2024.
• A 5-year view of Total Liabilities shows it stood at $65.7 billion in 2022, then retreated by 0.04% to $65.7 billion in 2023, then climbed by 16.05% to $76.2 billion in 2024, then fell by 6.14% to $71.5 billion in 2025, then slipped by 7.21% to $66.4 billion in 2026.
• Business Quant data shows BMY's Total Liabilities at $66.4 billion in Q1 2026, $71.5 billion in Q4 2025, and $78.3 billion in Q3 2025.